(Q43777263)

26 November 2017

1 reference

title

Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis (English)

1 reference

Human T-lymphotropic virus 1

26 November 2017

0 references

strongyloidiasis

0 references

author name string

Maria Aurélia F Porto

1

1 reference

26 November 2017

André Muniz

2

1 reference

26 November 2017

Jamary Oliveira Júnior

3

1 reference

26 November 2017

Edgar Marcelino Carvalho

4

1 reference

26 November 2017

language of work or name

Portuguese

0 references

publication date

1 November 2002

1 reference

Revista da Sociedade Brasileira de Medicina Tropical

26 November 2017

1 reference

26 November 2017

35

1 reference

26 November 2017

6

1 reference

26 November 2017

641-649

1 reference

Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies).

26 November 2017

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Immunomodulatory effects of concurrent HTLV-I infection in strongyloidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Human Th1 and Th2 T-cell clones are equally susceptible to infection and immortalization by human T-lymphotropic virus type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Lymphocyte alveolitis in HAM/TSP patients. Preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

High incidence of HTLV antibody in carriers of Strongyloides stercoralis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Selective effector mechanisms for the expulsion of intestinal helminths

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

HTLV-I associated myelopathy, a new clinical entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Arthritis associated with Strongyloides stercoralis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Case report: adult T-cell leukemia/lymphoma associated with recurrent strongyloides hyperinfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T-cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Granulomatous hepatitis due to Strongyloides stercoralis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Alteration of T-Cell Functions by Infection with HTLV-I or HTLV-II

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Influence of human T-cell lymphocytotropic virus type 1 infection on serologic and skin tests for strongyloidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Type 1 T helper and type 2 T helper cells: Functions, regulation and role in protection and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Concurrent infections with Strongyloides and T-cell leukemia virus and their possible effect on immune responses of host

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Reduced efficacy of chemotherapy might accumulate concurrent HTLV-1 infection among strongyloidiasis patients in Okinawa, Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

[Clinical study on ivermectin against 125 strongyloidiasis patients].

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

Antibody-dependent cell-mediated damage to schistosomula in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0037-86822002000600016

10.1590/S0037-86822002000600016

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference